GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Dex Liquidating Co (OTCPK:DXTRQ) » Definitions » EPS (Diluted)

Dex Liquidating Co (Dex Liquidating Co) EPS (Diluted) : $-1.98 (TTM As of Sep. 2017)


View and export this data going back to 2006. Start your Free Trial

What is Dex Liquidating Co EPS (Diluted)?

Dex Liquidating Co's Earnings per Share (Diluted) for the three months ended in Sep. 2017 was $-0.09. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2017 was $-1.98.

Dex Liquidating Co's EPS (Basic) for the three months ended in Sep. 2017 was $-0.09. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2017 was $-1.98.

Dex Liquidating Co's EPS without NRI for the three months ended in Sep. 2017 was $-0.09. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2017 was $-1.98.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Dex Liquidating Co EPS (Diluted) Historical Data

The historical data trend for Dex Liquidating Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dex Liquidating Co EPS (Diluted) Chart

Dex Liquidating Co Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.00 -3.24 -2.16 -1.79 -2.33

Dex Liquidating Co Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 -0.41 -0.50 -0.98 -0.09

Competitive Comparison of Dex Liquidating Co's EPS (Diluted)

For the Shell Companies subindustry, Dex Liquidating Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dex Liquidating Co's PE Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Dex Liquidating Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Dex Liquidating Co's PE Ratio falls into.



Dex Liquidating Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Dex Liquidating Co's Diluted EPS for the fiscal year that ended in Jun. 2017 is calculated as

Diluted EPS (A: Jun. 2017 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-17.226-8.704)/11.144
=-2.33

Dex Liquidating Co's Diluted EPS for the quarter that ended in Sep. 2017 is calculated as

Diluted EPS (Q: Sep. 2017 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.537-0.101)/45.199
=-0.08

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dex Liquidating Co  (OTCPK:DXTRQ) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Dex Liquidating Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Dex Liquidating Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Dex Liquidating Co (Dex Liquidating Co) Business Description

Traded in Other Exchanges
N/A
Address
7 West 41st Avenue, Suite 245, San Mateo, CA, USA, 94403
Dex Liquidating Co currently has no business operations.
Executives
Younger William H Jr other: Former Director 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Newell Robert Y Iv officer: V.P., Finance, CFO, Secretary 2309 BERING DRIVE, SAN JOSE CA 95131
Liam Burns officer: VP,Worldwide Sales & Marketing C/O MODULAR MEDICAL, INC., 800 W. VALLEY PARKWAY, SUITE 203, ESCONDIDO CA 92025
Gregory D Casciaro director 361 RAQUEL LANE, LOS ALTOS CA 94022
Samuel E Navarro director C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044
Richard M Ferrari 10 percent owner, other: See Explanation of Responses 2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Broadfin Healthcare Master Fund Ltd 10 percent owner, other: See Explanation of Responses C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Broadfin Capital, Llc 10 percent owner, other: See Explanation of Responses 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Kevin Kotler 10 percent owner, other: See Explanation of Responses C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Gary S Petersmeyer director 3400 CENTRAL AVENUE, SANTA CLARA CA 95051
James C Gaither 10 percent owner 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Baker G Leonard Jr 10 percent owner 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Tench Coxe 10 percent owner 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304
Pullara Samuel J Iii 10 percent owner 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304
Hill Ventures Sutter 10 percent owner 755 PAGE MILL RD, SUITE A200, PALO ALTO CA 94304

Dex Liquidating Co (Dex Liquidating Co) Headlines